-
341
Stemazole Promotes Oligodendrocyte Precursor Cell Survival In Vitro and Remyelination In Vivo
Published 2022-09-01“…In conclusion, stemazole promoted OPC survival in vitro and remyelination in vivo, suggesting that this compound may be used as a therapeutic agent against demyelinating disease.…”
Get full text
Article -
342
MOGAD Involving Cranial Neuropathies: A Case Report and Review of Literature
Published 2022-11-01“…Myelin-oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an autoimmune-mediated demyelinating disease of the central nervous system (CNS). …”
Get full text
Article -
343
Relation of Helicobacter pylori infection and multiple sclerosis in Iranian patients
Published 2013-06-01“…Multiple sclerosis (MS) is the most prevalent central nervous system demyelinating disease. There are known risk factors for MS. …”
Get full text
Article -
344
Microglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis
Published 2020-08-01“…Multiple sclerosis (MS) is the most common autoimmune and demyelinating disease of the central nervous system (CNS), characterized, in the majority of cases, by initial relapses that later evolve into progressive neurodegeneration, severely impacting patients’ motor and cognitive functions. …”
Get full text
Article -
345
Induction of Brain Tumors by the Archetype Strain of Human Neurotropic JCPyV in a Transgenic Mouse Model
Published 2021-01-01“…JCPyV is the established opportunistic infectious agent of progressive multifocal leukoencephalopathy, a fatal demyelinating disease, which results from the cytolytic infection of oligodendrocytes. …”
Get full text
Article -
346
Esclerose múltipla: implicações sócio-económicas.
Published 2010-07-01“…Multiple Sclerosis (MS) is the most common demyelinating disease of the Central Nervous System. It is more frequently diagnosed in young individuals between 20 and 40 years old. …”
Get full text
Article -
347
The Relationship between Cognitive Dysfunction and Postural Stability in Multiple Sclerosis
Published 2021-12-01“…<i>Background and Objectives</i>: Multiple Sclerosis (MS) is a demyelinating disease of the central nervous system (CNS), most commonly characterized by balance dysfunction, fatigue syndrome and cognitive impairment. …”
Get full text
Article -
348
Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets
Published 2023-02-01“…Multiple sclerosis (MS) is an autoimmune-mediated demyelinating disease of the central nervous system. The main pathological features are inflammatory reaction, demyelination, axonal disintegration, reactive gliosis, etc. …”
Get full text
Article -
349
Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis
Published 2010-06-01“…<p>Abstract</p> <p>Background</p> <p>Neuromyelitis optica (NMO) is an inflammatory demyelinating disease that predominantly affects the optic nerves and the spinal cord, and is possibly mediated by an immune mechanism distinct from that of multiple sclerosis (MS). …”
Get full text
Article -
350
Resveratrol Neuroprotection in a Chronic Mouse Model of Multiple Sclerosis
Published 2012-05-01“…Results demonstrate that resveratrol prevents neuronal loss in this chronic demyelinating disease model, similar to its effects in relapsing EAE. …”
Get full text
Article -
351
A Review of Compartmentalised Inflammation and Tertiary Lymphoid Structures in the Pathophysiology of Multiple Sclerosis
Published 2022-10-01“…Multiple sclerosis (MS) is a chronic, immune-mediated, demyelinating disease of the central nervous system (CNS). …”
Get full text
Article -
352
A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots
Published 2021-01-01“…One significant characteristic of Multiple Sclerosis (MS), a chronic inflammatory demyelinating disease of the central nervous system, is the evolution of highly variable patterns of white matter lesions. …”
Get full text
Article -
353
Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway
Published 2018-10-01“…Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). …”
Get full text
Article -
354
Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model
Published 2017-12-01“…Together, these data have implications for understanding the role of BBB permeability in the pathogenesis of demyelinating disease.…”
Get full text
Article -
355
Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers
Published 2021-07-01“…Multiple Sclerosis (MS) is a demyelinating disease of the human central nervous system having an unconfirmed pathoetiology. …”
Get full text
Article -
356
Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease
Published 2013-05-01“…METHODS: Patients with a first event of presumed demyelinating disease (CIS), multiple sclerosis relapses (MS) or sub-acute disease progression were treated with a 5-day regimen of intravenous methylprednisolone (IVMP) in our inpatient clinic. …”
Get full text
Article -
357
Study the Effect of Melatonin on Fatigue in Patients with Multiple Sclerosis
Published 2018-12-01“…Background and Aim: Multiple Sclerosis is (MS) is a common demyelinating disease of CNS that inflammation and stress oxidative processes have an important role in clinical courses and progression of it. …”
Get full text
Article -
358
"Clinical Course and prognosis of 203 patients with MS in shahid Mostafa Khomeini Hospital, Tehran 2002 "
Published 2006-08-01“…Background: Multiples sclerosis is a common demyelinating disease of CNS and the main cause of disability in young adults all over the world so any research in different aspects of the disease has great value. researches in Iran are few in quantity and low in sample size. …”
Get full text
Article -
359
Optic neuritis updates (ORP-57)
Published 2023-01-01“…It was considered as a presentation of multiple sclerosis for decades, however Multiple sclerosis is the most common demyelinating disease associated with optic neuritis , it is important to differentiate from other auto immune processes such as NMOSD , MOGAD , GFAP-IgG-associated optic neuropathy, CRMP5-IgG-associated optic neuropathy . …”
Get full text
Article -
360
The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis.
Published 2000“…Although multiple sclerosis (MS) is an inflammatory demyelinating disease, there can be substantial axonal injury and loss. …”
Journal article